Daré Bioscience Debuts CEO Video Series on Women's Health Strategy
Daré Bioscience launched a video series called CEO Corner, featuring founder, president, and CEO Sabrina Martucci Johnson. The series is meant to give investors more detail on the company's commercial portfolio, clinical pipeline, and strategic priorities. It also highlights Daré's shift toward becoming a commercial-stage women's health company.
Daré Bioscience, a Nasdaq-listed biotech based in San Diego, introduced CEO Corner on Oct. 13, 2026. The video series features Sabrina Martucci Johnson, the company’s founder, president, and chief executive, discussing its commercial portfolio, clinical pipeline, and strategic priorities.
Later installments are expected to cover development programs, upcoming milestones, and long-term value creation. The latest episode is available at darebioscience.com/ceocorner and remains accessible for about 90 days after release. The company describes itself as focused on women’s health, spanning contraception, menopause, sexual health, fertility, vaginal health, and infectious disease.
This investor-focused series may help shareholders and potential investors better understand Daré’s women’s health work, potentially improving transparency around its commercial and clinical progress. For patients and clinicians, greater visibility could support awareness of emerging options in contraception, menopause, sexual health, fertility, vaginal health, and infectious disease, though the videos themselves do not introduce new treatments. Its societal effect likely depends on whether the company’s pipeline ultimately delivers accessible, proven products.